After listening to feedback from prescribers, dispensers and people living with HIV, Gilead Sciences is delighted to announce the launch of a postal HIV Medication Access Program throughout Australia.
An announcement from Jaime McCoy, General Manager and Paul Slade, Senior Medical Director of Gilead Sciences Australia and New Zealand on the impact of COVID-19.
On 10 March 2020, a special lunchtime session was held as part of the Conference on Retroviruses and Opportunistic Infections (CROI) 2020 to provide up-to-date information on the 2019-novel coronavirus (COVID-19) outbreak and its causative pathogen,
Scroll down to watch the video below from our new General Manager, Jaime McCoy, as she describes the role Gilead will continue to play within the HIV community.
6–9 November 2019 // Basel, Switzerland
Over the 6-9 November, the 17th European AIDS Conference was held in Basel, Switzerland.
The European AIDS Conference is a biennial conference which aims to bring together scientists from across Europe to share the latest clinical research and developments in the field of HIV, and is in instrumental in shaping the future of HIV science and medicine.
8–12 December 2019 // Adelaide, SA
Visit https://www.asi2019.org/ for details on the program and topics – which will include infectious diseases.